NRC Health Common Stock
NRC
116 hedge funds and large institutions have $508M invested in NRC Health Common Stock in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 47 increasing their positions, 35 reducing their positions, and 16 closing their positions.
34% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 35
2% more capital invested
Capital invested by funds: $499M → $508M (+$9.14M)
0.85% more ownership
Funds ownership: 46.54% → 47.39% (+0.85%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 124 → 116 (-8)
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $21K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.87M |
| 2 |
BlackRock
New York
|
+$2.79M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$2.35M |
| 4 |
LTAS
Linden Thomas Advisory Services
Charlotte,
North Carolina
|
+$1.22M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.19M |
| 2 |
BA
Bridgewater Associates
Westport,
Connecticut
|
-$1.01M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$502K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$502K |
| 5 |
Jane Street
New York
|
-$412K |
NRC Hedge Fund Activity: Q2 2023 in Review
116 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q2 2023, worth a combined $508M — up 1.8% from $499M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of NRC and 8 opened new positions — a net loss of 8 holders — while 35 trimmed existing stakes and 47 added.
The largest buyer was Vanguard Group, adding an estimated $4.87M. The largest seller was Morgan Stanley, cutting an estimated $1.19M.
- 116 institutional investors held NRC Health Common Stock (NRC) as of Q2 2023, down from 124 in Q1 2023.
- Funds reported $508M of NRC Health Common Stock stock for Q2 2023, up 1.8% quarter-over-quarter.
- 8 funds opened new NRC Health Common Stock positions in Q2 2023 and 16 closed out, a net change of -8 holders.
- The largest NRC Health Common Stock buyer in Q2 2023 was Vanguard Group, an estimated $4.87M added.
- The largest NRC Health Common Stock seller in Q2 2023 was Morgan Stanley, an estimated $1.19M sold.
Based on aggregated 13F filings for Q2 2023.